Diet Intervention for Pregnancy Microbiome
(MOMS Trial)
Trial Summary
What is the purpose of this trial?
The purpose of the study is to learn how different dietary interventions affect microbiota diversity in pregnant women and the transmission of microbiota to their infants during pregnancy, birth, and postpartum.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are taking weight loss medications, regular high dose aspirin, or regular prescription opiate pain medication, you may not be eligible to participate. Additionally, if you have taken certain medications like antibiotics or corticosteroids in the past two months, you may also be excluded.
What data supports the effectiveness of the treatment Fermented Foods, Fiber, Dietary Fiber for pregnancy microbiome?
Research suggests that high dietary fiber intake during pregnancy can positively influence the gut microbiome by promoting beneficial bacteria, which may help regulate glucose metabolism and reduce inflammation. Additionally, whole grains, which are high in fiber, may affect the vaginal microbiome, potentially benefiting maternal and neonatal health.12345
Is it safe to consume whole grains and high-fiber foods during pregnancy?
How does the treatment of fermented foods and fiber for pregnancy microbiome differ from other treatments?
This treatment is unique because it focuses on altering the gut microbiome through dietary changes, specifically by increasing the intake of fermented foods and fiber, which can enhance beneficial bacteria and reduce inflammation. Unlike other treatments that might use medications, this approach leverages natural dietary components to improve gut health and potentially influence immune function.910111213
Research Team
Christopher D Garnder, PhD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for healthy pregnant women over 18, in their first trimester up to 22 weeks. Participants must be carrying a single baby and able to give samples of blood, stool, vaginal swab, and breast milk. They cannot join if they have severe obesity, high blood pressure, certain diseases (like autoimmune or liver disease), recent GI surgery (except gallbladder or appendix removal), or are immunocompromised.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline and Randomization
Baseline visit and sample collection followed by randomization to dietary intervention groups
Treatment
Participants follow assigned dietary interventions and provide periodic samples
Postpartum Follow-up
Participants and infants are monitored for microbiome diversity and health markers
Extension
Optional continuation to assess long-term dietary impacts on microbiome
Treatment Details
Interventions
- Fermented Foods
- Fiber
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor